AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

UroGen Pharma Ltd. Director's Dealing 2020

Feb 13, 2020

32312_dirs_2020-02-13_00c6ff76-4a91-457f-967c-9e2bab4924b0.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2019-01-01

Reporting Person: Schoenberg Mark (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	12986	Direct

Footnotes

F1: 7,699 ordinary shares were omitted from the Reporting Person's original Form 3, as amended on March 7, 2019.